Phenyl ethynyl derivatives as hepatitis C virus inhibitors

Details for Australian Patent Application No. 2010280711 (hide)

Owner Tibotec Pharmaceuticals

Inventors Mc Gowan, David; Demin, Samuel Dominique; Last, Stefaan Julien; Vandyck, Koen; Raboisson, Pierre Jean-Marie Bernard

Agent Shelston IP

Pub. Number AU-A-2010280711

PCT Pub. Number WO2011/015657

Priority 09167438.2 07.08.09 EP

Filing date 6 August 2010

Wipo publication date 10 February 2011

International Classifications

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/4178 (2006.01)

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 407/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

Event Publications

9 February 2012 PCT application entered the National Phase

  PCT publication WO2011/015657 Priority application(s): WO2011/015657

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010280712-Bis-benzimidazole derivatives as hepatitis C virus inhibitors

2010280710-Composition for treating HBV infection